These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PSA AND Diagnosis
88 results:

  • 1. Outcomes of 10 years of psa screening for prostate cancer in Norwegian men with Lynch syndrome.
    Grindedal EM; Zucknick M; Stormorken A; Rønne E; Tandstad NM; Isaacs WB; Axcrona K; Mæhle L
    Prostate; 2024 Jul; 84(10):945-953. PubMed ID: 38629217
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. "Shared decision-making" for prostate cancer screening: Is it a marker of quality preventative healthcare?
    Golijanin B; Bhatt V; Homer A; Malshy K; Ochsner A; Wales R; Khaleel S; Mega A; Pareek G; Hyams E
    Cancer Epidemiol; 2024 Feb; 88():102492. PubMed ID: 38056246
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Latin America and the Caribbean Code Against cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening.
    Baena A; Paolino M; Villarreal-Garza C; Torres G; Delgado L; Ruiz R; Canelo-Aybar C; Song Y; Feliu A; Maza M; Jeronimo J; Espina C; Almonte M
    Cancer Epidemiol; 2023 Oct; 86 Suppl 1():102446. PubMed ID: 37852728
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Screening practices of cancer survivors and individuals whose family or friends had a cancer diagnoses-a nationally representative cross-sectional survey in Japan (INFORM Study 2020).
    Akiyama M; Ishida N; Takahashi H; Takahashi M; Otsuki A; Sato Y; Saito J; Yaguchi-Saito A; Fujimori M; Kaji Y; Shimazu T;
    J Cancer Surviv; 2023 Jun; 17(3):663-676. PubMed ID: 37041402
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The survival of the prostate cancer patients with secondary colorectal cancer: a study based on a SEER database from southern China.
    Lin L; Huang L; Li YL; Shan H
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):1128-1133. PubMed ID: 36808373
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High Throughput Isolation and Data Independent Acquisition Mass Spectrometry (DIA-MS) of Urinary Extracellular Vesicles to Improve Prostate cancer diagnosis.
    Zhang H; Zhang GY; Su WC; Chen YT; Liu YF; Wei D; Zhang YX; Tang QY; Liu YX; Wang SZ; Li WC; Wesselius A; Zeegers MP; Zhang ZY; Gu YH; Tao WA; Yu EY
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500247
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
    Bancroft EK; Page EC; Brook MN; Thomas S; Taylor N; Pope J; McHugh J; Jones AB; Karlsson Q; Merson S; Ong KR; Hoffman J; Huber C; Maehle L; Grindedal EM; Stormorken A; Evans DG; Rothwell J; Lalloo F; Brady AF; Bartlett M; Snape K; Hanson H; James P; McKinley J; Mascarenhas L; Syngal S; Ukaegbu C; Side L; Thomas T; Barwell J; Teixeira MR; Izatt L; Suri M; Macrae FA; Poplawski N; Chen-Shtoyerman R; Ahmed M; Musgrave H; Nicolai N; Greenhalgh L; Brewer C; Pachter N; Spigelman AD; Azzabi A; Helfand BT; Halliday D; Buys S; Ramon Y Cajal T; Donaldson A; Cooney KA; Harris M; McGrath J; Davidson R; Taylor A; Cooke P; Myhill K; Hogben M; Aaronson NK; Ardern-Jones A; Bangma CH; Castro E; Dearnaley D; Dias A; Dudderidge T; Eccles DM; Green K; Eyfjord J; Falconer A; Foster CS; Gronberg H; Hamdy FC; Johannsson O; Khoo V; Lilja H; Lindeman GJ; Lubinski J; Axcrona K; Mikropoulos C; Mitra AV; Moynihan C; Ni Raghallaigh H; Rennert G; Collier R; ; Offman J; Kote-Jarai Z; Eeles RA
    Lancet Oncol; 2021 Nov; 22(11):1618-1631. PubMed ID: 34678156
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prostate cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing psa Screening.
    Pierre-Victor D; Parnes HL; Andriole GL; Pinsky PF
    Urology; 2021 Sep; 155():62-69. PubMed ID: 34186135
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Trends in population-based cancer survival in Slovenia.
    Zadnik V; Zagar T; Lokar K; Tomsic S; Konjevic AD; Zakotnik B
    Radiol Oncol; 2021 Jan; 55(1):42-49. PubMed ID: 33885247
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia.
    Khan S; Wolin KY; Pakpahan R; Grubb RL; Colditz GA; Ragard L; Mabie J; Breyer BN; Andriole GL; Sutcliffe S
    BMC Urol; 2021 Mar; 21(1):47. PubMed ID: 33773592
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Factors Associated with cancer Screening Among Hopi Men.
    Batai K; Sanderson PR; Hsu CH; Joshweseoma L; Russell D; Joshweseoma L; Ojeda J; Burhansstipanov L; Brown SR; Ami D; Saboda K; Harris RB
    J Cancer Educ; 2022 Aug; 37(4):915-923. PubMed ID: 33083892
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Metachronous Pubic Bone Metastases from Synchronous Double cancer with Prostate and Ascending Colon cancers : A Case Report].
    Ito H; Hishida S; Taniguchi T; Kato D; Takai M; Iinuma K; Muramatsu-Maekawa Y; Kato T; Nakane K; Mizutani K; Tsuchiya T; Takahashi T; Suzui N; Miyazaki T; Koie T
    Hinyokika Kiyo; 2020 Aug; 66(8):273-277. PubMed ID: 32882125
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies.
    Graham LS; Montgomery B; Cheng HH; Yu EY; Nelson PS; Pritchard C; Erickson S; Alva A; Schweizer MT
    PLoS One; 2020; 15(5):e0233260. PubMed ID: 32453797
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Incidental Finding of Colon Carcinoma Related to High Uptake in 18F-PSMA-1007 PET.
    Arçay A; Eiber M; Langbein T
    Clin Nucl Med; 2020 Jul; 45(7):561-562. PubMed ID: 32433166
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Substantial tumor regression in prostate cancer patient with extensive skeletal metastases upon Immunotherapy (APCEDEN): A case report.
    Sharan B; Chiliveru S; Bagga J; Kohli S; Bharadwaj A; Vaid AK; Kumar C
    Medicine (Baltimore); 2020 Feb; 99(8):e18889. PubMed ID: 32080073
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association of Baseline Prostate-Specific Antigen Level With Long-term diagnosis of Clinically Significant Prostate cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, colorectal, and Ovarian (PLCO) cancer Screening Trial.
    Kovac E; Carlsson SV; Lilja H; Hugosson J; Kattan MW; Holmberg E; Stephenson AJ
    JAMA Netw Open; 2020 Jan; 3(1):e1919284. PubMed ID: 31940039
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [A Case of Rectum-Infiltrating Prostate cancer Mimicking Prostate-Infiltrating Rectal cancer].
    Hishiki K; Takada H; Nakashima Y; Kohei N; Nishio Y; Muro H; Ohata K; Yoshimura K
    Hinyokika Kiyo; 2018 Sep; 64(9):373-377. PubMed ID: 30369229
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, colorectal and Ovarian randomized cancer screening trial.
    Pinsky PF; Miller E; Prorok P; Grubb R; Crawford ED; Andriole G
    BJU Int; 2019 May; 123(5):854-860. PubMed ID: 30288918
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Sigmoid Colon Adenocarcinoma with Isolated Loss of PMS2 Presenting in a Patient with Synchronous Prostate cancer with Intact MMR: diagnosis and Analysis of the Family Pedigree.
    Liu W; Zhang D; Tan SA; Liu X; Lai J
    Anticancer Res; 2018 Aug; 38(8):4847-4852. PubMed ID: 30061258
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 5.